相似文献
1
Comparison of agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of ramoplanin MICs.
J Clin Microbiol. 1994 May;32(5):1364-5. doi: 10.1128/jcm.32.5.1364-1365.1994.
2
Effect of protein on ramoplanin broth microdilution minimum inhibitory concentrations.
Diagn Microbiol Infect Dis. 1993 Oct;17(3):209-11. doi: 10.1016/0732-8893(93)90098-r.
3
Ramoplanin susceptibility testing criteria.
J Clin Microbiol. 1993 Jul;31(7):1932-5. doi: 10.1128/jcm.31.7.1932-1935.1993.
4
Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies.
Antimicrob Agents Chemother. 2006 May;50(5):1727-30. doi: 10.1128/AAC.50.5.1727-1730.2006.
5
Comparison of the agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of teicoplanin MICs.
J Clin Microbiol. 1989 Jun;27(6):1409-10. doi: 10.1128/jcm.27.6.1409-1410.1989.
6
Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.
J Clin Microbiol. 1997 Dec;35(12):3258-63. doi: 10.1128/jcm.35.12.3258-3263.1997.
7
Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens.
J Clin Microbiol. 2010 Sep;48(9):3353-7. doi: 10.1128/JCM.00494-10. Epub 2010 Jun 30.
8
Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.
J Clin Microbiol. 1991 Mar;29(3):533-8. doi: 10.1128/jcm.29.3.533-538.1991.
9
Comparison of minimum inhibitory concentration results for gepotidacin obtained using agar dilution and broth microdilution methods.
Diagn Microbiol Infect Dis. 2020 Oct;98(2):115107. doi: 10.1016/j.diagmicrobio.2020.115107. Epub 2020 Jun 11.
10
Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli.
J Clin Microbiol. 2003 Mar;41(3):1062-8. doi: 10.1128/JCM.41.3.1062-1068.2003.
引用本文的文献
1
Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus.
Antimicrob Agents Chemother. 2014 Nov;58(11):6819-27. doi: 10.1128/AAC.00061-14. Epub 2014 Sep 2.
2
Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing.
Antimicrob Agents Chemother. 2008 May;52(5):1597-603. doi: 10.1128/AAC.01513-07. Epub 2008 Feb 25.
本文引用的文献
1
In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
Antimicrob Agents Chemother. 1993 Apr;37(4):896-900. doi: 10.1128/AAC.37.4.896.
2
Ramoplanin susceptibility testing criteria.
J Clin Microbiol. 1993 Jul;31(7):1932-5. doi: 10.1128/jcm.31.7.1932-1935.1993.
3
In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms.
Antimicrob Agents Chemother. 1993 Jun;37(6):1364-6. doi: 10.1128/AAC.37.6.1364.
4
Effect of protein on ramoplanin broth microdilution minimum inhibitory concentrations.
Diagn Microbiol Infect Dis. 1993 Oct;17(3):209-11. doi: 10.1016/0732-8893(93)90098-r.
5
Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation.
J Antibiot (Tokyo). 1989 Feb;42(2):254-67. doi: 10.7164/antibiotics.42.254.
6
In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use.
Diagn Microbiol Infect Dis. 1989 May-Jun;12(3):279-82. doi: 10.1016/0732-8893(89)90029-1.
Zotero 插件